25 XP   0   0   10

PDS Biotechnology Corp
Buy, Hold or Sell?

Let's analyse PDS Biotechnology Corp together

PenkeI guess you are interested in PDS Biotechnology Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of PDS Biotechnology Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about PDS Biotechnology Corp

I send you an email if I find something interesting about PDS Biotechnology Corp.

Quick analysis of PDS Biotechnology Corp (30 sec.)










What can you expect buying and holding a share of PDS Biotechnology Corp? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
2.7%

What is your share worth?

Current worth
$0.83
Expected worth in 1 year
$0.24
How sure are you?
18.9%

+ What do you gain per year?

Total Gains per Share
$-0.59
Return On Investment
-18.1%

For what price can you sell your share?

Current Price per Share
$3.25
Expected price per share
$0 - $4.94
How sure are you?
50%

1. Valuation of PDS Biotechnology Corp (5 min.)




Live pricePrice per Share (EOD)

$3.25

Intrinsic Value Per Share

$-11.29 - $-13.26

Total Value Per Share

$-10.46 - $-12.43

2. Growth of PDS Biotechnology Corp (5 min.)




Is PDS Biotechnology Corp growing?

Current yearPrevious yearGrowGrow %
How rich?$26.1m$49.5m-$18.5m-59.9%

How much money is PDS Biotechnology Corp making?

Current yearPrevious yearGrowGrow %
Making money-$10.7m-$10.8m$76.9k0.7%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of PDS Biotechnology Corp (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#544 / 1010

Most Revenue
#945 / 1010

Most Profit
#579 / 1010

Most Efficient
#386 / 1010

What can you expect buying and holding a share of PDS Biotechnology Corp? (5 min.)

Welcome investor! PDS Biotechnology Corp's management wants to use your money to grow the business. In return you get a share of PDS Biotechnology Corp.

What can you expect buying and holding a share of PDS Biotechnology Corp?

First you should know what it really means to hold a share of PDS Biotechnology Corp. And how you can make/lose money.

Speculation

The Price per Share of PDS Biotechnology Corp is $3.25. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of PDS Biotechnology Corp.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in PDS Biotechnology Corp, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.83. Based on the TTM, the Book Value Change Per Share is $-0.15 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.15 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of PDS Biotechnology Corp.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.34-10.6%-0.34-10.6%-0.33-10.1%-0.20-6.1%-0.20-6.3%
Usd Book Value Change Per Share0.041.2%-0.15-4.5%-0.15-4.7%-0.01-0.2%0.020.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.041.2%-0.15-4.5%-0.15-4.7%-0.01-0.2%0.020.7%
Usd Price Per Share4.97-5.30-6.50-5.70-6.01-
Price to Earnings Ratio-3.61--3.89--4.76--13.36--16.70-
Price-to-Total Gains Ratio130.60-7.16--51.82--26.53--21.85-
Price to Book Ratio6.02-5.48-4.24-5.14-3.56-
Price-to-Total Gains Ratio130.60-7.16--51.82--26.53--21.85-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.25
Number of shares307
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.15-0.01
Usd Total Gains Per Share-0.15-0.01
Gains per Quarter (307 shares)-45.24-2.06
Gains per Year (307 shares)-180.94-8.23
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-181-1910-8-18
20-362-3720-16-26
30-543-5530-25-34
40-724-7340-33-42
50-905-9150-41-50
60-1086-10960-49-58
70-1267-12770-58-66
80-1448-14580-66-74
90-1628-16390-74-82
100-1809-18200-82-90

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%1.019.00.05.0%1.036.00.02.7%1.036.00.02.7%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%4.016.00.020.0%7.029.01.018.9%7.029.01.018.9%
Dividend per Share0.00.04.00.0%1.00.011.08.3%1.00.019.05.0%1.00.036.02.7%1.00.036.02.7%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%4.016.00.020.0%7.029.01.018.9%7.029.01.018.9%

Fundamentals of PDS Biotechnology Corp

About PDS Biotechnology Corp

PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, and human papillomavirus associated malignancies. The company is developing various product candidates, which are in preclinical trials, including PDS0102 T-cell receptor gamma alternate reading frame protein (TARP) for treating prostate and breast cancers; PDS0103 (MUC-1) for ovarian, colorectal, lung, and breast cancers; and PDS0104, which include Tyrosinase-related protein 2 for the treatment of melanoma. In addition, it is developing PDS0201 for treating tuberculosis; PDS0202, an influenza vaccine candidate; and PDS0203, a vaccine for the prevention of COVID-19. The company has a license and collaboration agreements with National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, and MSD International GmbH. PDS Biotechnology Corporation was founded in 2005 and is based in Florham Park, New Jersey.

Fundamental data was last updated by Penke on 2024-04-12 14:49:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of PDS Biotechnology Corp.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit PDS Biotechnology Corp earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare PDS Biotechnology Corp to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of PDS Biotechnology Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--200.1%+200.1%
TTM--216.8%+216.8%
YOY--288.3%+288.3%
5Y--449.1%+449.1%
10Y--605.5%+605.5%
1.1.2. Return on Assets

Shows how efficient PDS Biotechnology Corp is using its assets to generate profit.

  • Above 5% is considered healthy but always compare PDS Biotechnology Corp to the Biotechnology industry mean.
  • -18.4% Return on Assets means that PDS Biotechnology Corp generated $-0.18 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of PDS Biotechnology Corp:

  • The MRQ is -18.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -17.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-18.4%TTM-17.4%-1.0%
TTM-17.4%YOY-15.5%-1.8%
TTM-17.4%5Y-13.5%-3.9%
5Y-13.5%10Y-13.6%+0.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-18.4%-13.3%-5.1%
TTM-17.4%-12.8%-4.6%
YOY-15.5%-11.7%-3.8%
5Y-13.5%-13.9%+0.4%
10Y-13.6%-15.7%+2.1%
1.1.3. Return on Equity

Shows how efficient PDS Biotechnology Corp is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare PDS Biotechnology Corp to the Biotechnology industry mean.
  • -41.7% Return on Equity means PDS Biotechnology Corp generated $-0.42 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of PDS Biotechnology Corp:

  • The MRQ is -41.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -36.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-41.7%TTM-36.3%-5.4%
TTM-36.3%YOY-22.8%-13.5%
TTM-36.3%5Y-19.9%-16.4%
5Y-19.9%10Y-17.1%-2.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-41.7%-16.9%-24.8%
TTM-36.3%-16.1%-20.2%
YOY-22.8%-15.1%-7.7%
5Y-19.9%-19.3%-0.6%
10Y-17.1%-20.2%+3.1%

1.2. Operating Efficiency of PDS Biotechnology Corp.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient PDS Biotechnology Corp is operating .

  • Measures how much profit PDS Biotechnology Corp makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare PDS Biotechnology Corp to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of PDS Biotechnology Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--296.2%+296.2%
TTM--232.5%+232.5%
YOY--298.2%+298.2%
5Y--492.1%+492.1%
10Y--632.4%+632.4%
1.2.2. Operating Ratio

Measures how efficient PDS Biotechnology Corp is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of PDS Biotechnology Corp:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.231-3.231
TTM-3.310-3.310
YOY-3.890-3.890
5Y-5.739-5.739
10Y-7.876-7.876

1.3. Liquidity of PDS Biotechnology Corp.

1.3. Liquidity
1.3.1. Current Ratio

Measures if PDS Biotechnology Corp is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.33 means the company has $4.33 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of PDS Biotechnology Corp:

  • The MRQ is 4.333. The company is very able to pay all its short-term debts. +2
  • The TTM is 8.754. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.333TTM8.754-4.422
TTM8.754YOY11.901-3.146
TTM8.7545Y10.199-1.445
5Y10.19910Y10.221-0.022
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.3333.890+0.443
TTM8.7544.173+4.581
YOY11.9015.344+6.557
5Y10.1996.126+4.073
10Y10.2216.448+3.773
1.3.2. Quick Ratio

Measures if PDS Biotechnology Corp is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare PDS Biotechnology Corp to the Biotechnology industry mean.
  • A Quick Ratio of 4.15 means the company can pay off $4.15 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of PDS Biotechnology Corp:

  • The MRQ is 4.150. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 8.384. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.150TTM8.384-4.234
TTM8.384YOY11.445-3.062
TTM8.3845Y9.735-1.351
5Y9.73510Y9.906-0.171
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1503.514+0.636
TTM8.3843.998+4.386
YOY11.4455.380+6.065
5Y9.7356.105+3.630
10Y9.9066.404+3.502

1.4. Solvency of PDS Biotechnology Corp.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of PDS Biotechnology Corp assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare PDS Biotechnology Corp to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.56 means that PDS Biotechnology Corp assets are financed with 56.0% credit (debt) and the remaining percentage (100% - 56.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of PDS Biotechnology Corp:

  • The MRQ is 0.560. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.506. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.560TTM0.506+0.054
TTM0.506YOY0.242+0.264
TTM0.5065Y0.231+0.275
5Y0.23110Y0.396-0.164
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5600.339+0.221
TTM0.5060.336+0.170
YOY0.2420.271-0.029
5Y0.2310.366-0.135
10Y0.3960.389+0.007
1.4.2. Debt to Equity Ratio

Measures if PDS Biotechnology Corp is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare PDS Biotechnology Corp to the Biotechnology industry mean.
  • A Debt to Equity ratio of 127.3% means that company has $1.27 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of PDS Biotechnology Corp:

  • The MRQ is 1.273. The company is able to pay all its debts with equity. +1
  • The TTM is 1.061. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.273TTM1.061+0.212
TTM1.061YOY0.381+0.680
TTM1.0615Y0.386+0.674
5Y0.38610Y0.315+0.071
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2730.388+0.885
TTM1.0610.402+0.659
YOY0.3810.335+0.046
5Y0.3860.426-0.040
10Y0.3150.461-0.146

2. Market Valuation of PDS Biotechnology Corp

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings PDS Biotechnology Corp generates.

  • Above 15 is considered overpriced but always compare PDS Biotechnology Corp to the Biotechnology industry mean.
  • A PE ratio of -3.61 means the investor is paying $-3.61 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of PDS Biotechnology Corp:

  • The EOD is -2.361. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.611. Based on the earnings, the company is expensive. -2
  • The TTM is -3.893. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.361MRQ-3.611+1.250
MRQ-3.611TTM-3.893+0.283
TTM-3.893YOY-4.759+0.865
TTM-3.8935Y-13.356+9.463
5Y-13.35610Y-16.700+3.343
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.361-2.264-0.097
MRQ-3.611-2.629-0.982
TTM-3.893-2.680-1.213
YOY-4.759-4.145-0.614
5Y-13.356-6.257-7.099
10Y-16.700-6.254-10.446
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of PDS Biotechnology Corp:

  • The EOD is -3.043. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.653. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.469. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.043MRQ-4.653+1.610
MRQ-4.653TTM-5.469+0.817
TTM-5.469YOY-7.477+2.008
TTM-5.4695Y-2.734-2.735
5Y-2.73410Y-4.302+1.568
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.043-2.973-0.070
MRQ-4.653-3.333-1.320
TTM-5.469-3.553-1.916
YOY-7.477-5.605-1.872
5Y-2.734-8.376+5.642
10Y-4.302-8.865+4.563
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of PDS Biotechnology Corp is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 6.02 means the investor is paying $6.02 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of PDS Biotechnology Corp:

  • The EOD is 3.939. Based on the equity, the company is fair priced.
  • The MRQ is 6.023. Based on the equity, the company is overpriced. -1
  • The TTM is 5.482. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD3.939MRQ6.023-2.085
MRQ6.023TTM5.482+0.542
TTM5.482YOY4.237+1.244
TTM5.4825Y5.135+0.347
5Y5.13510Y3.560+1.575
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.9391.896+2.043
MRQ6.0232.115+3.908
TTM5.4822.093+3.389
YOY4.2372.884+1.353
5Y5.1353.542+1.593
10Y3.5603.916-0.356
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of PDS Biotechnology Corp.

3.1. Institutions holding PDS Biotechnology Corp

Institutions are holding 27.028% of the shares of PDS Biotechnology Corp.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31BlackRock Inc6.04810.00021881438779554.3225
2023-09-30Vanguard Group Inc4.84670.00021507691-117456-7.2274
2023-09-30Geode Capital Management, LLC1.93320.0004601360239664.1507
2023-09-30State Street Corporation1.62320.00015049414796610.4964
2023-09-30TANG CAPITAL MANAGEMENT LLC1.28590.285400000300000300
2023-12-31Integrys Wealth Advisors LLC1.0820.312433659457201.7288
2023-09-30Northern Trust Corp0.7920.000224637982303.4558
2023-09-30LPL Financial Corp0.75470.0008234777-70685-23.1404
2023-09-30Susquehanna International Group, LLP0.58040.00021805372458515.7645
2023-12-31Sofinnova Ventures0.45850.039714263500
2023-12-31Renaissance Technologies Corp0.3880.00091207001207000
2023-12-31Two Sigma Advisers, LLC0.35070.0013109100-142300-56.603
2023-09-30Bank of New York Mellon Corp0.34980.0001108826-745-0.6799
2023-09-30Nuveen Asset Management, LLC0.33820.000210520100
2023-09-30Citadel Advisors Llc0.30860.0001959894513888.7652
2023-09-30Charles Schwab Investment Management Inc0.24820.00017720300
2023-12-31Amussen, Hunsaker & Associates Incorporated0.24110.07377501600
2023-09-30Morgan Stanley - Brokerage Accounts0.221206881815472.2997
2023-09-30Commonwealth Equity Services Inc0.2140.00076657830254.7598
2023-09-30Mirae Asset Global Investments (Korea) Co Ltd0.16580.00065157600
Total 22.23030.71696915359+327646+4.7%

3.2. Funds holding PDS Biotechnology Corp

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv2.53190.000492868400
2024-03-28iShares Russell 2000 ETF1.95580.00437173733450.0481
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.17540.002843114400
2024-01-31Fidelity Small Cap Index0.77010.006128247455682.0108
2024-03-28iShares Russell 2000 Growth ETF0.65740.0082241129-280-0.116
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.47820.002817540000
2024-02-29Fidelity Extended Market Index0.46350.0029170003-824-0.4824
2024-03-31State St Russell Sm Cap® Indx SL Cl I0.28080.004210300000
2024-02-29Vanguard Russell 2000 ETF0.28040.007110284878328.2428
2023-12-31NT R2000 Growth Index Fund - NL0.2290.01138400200
2023-12-31NT R2000 Index Fund - NL0.21970.0055805671380.1716
2024-03-31BlackRock Extended Equity Market K0.21280.002178037280.0359
2023-09-30BlackRock Extended Mkt Composite0.18360.0024673394890.7315
2024-01-31TIAA-CREF Equity Index Instl0.18270.00096700200
2023-12-31Northern Trust Russell 2000 Growth Index0.17630.01166465441066.7814
2023-12-31NT R2000 Growth Index Fund - L0.17630.01166465441066.7814
2024-02-29Schwab Small Cap Index0.17430.00716392500
2023-12-31NT R2000 Index Fund - DC - NL - 20.1730.005563447-136-0.2139
2024-03-28iShares Micro-Cap ETF0.16840.02666178100
2024-03-31Russell 2000 Index Non-Lendable Fund E0.15090.0042553471034722.9933
Total 10.64050.12763902810+31719+0.8%

3.3. Insider Transactions

Insiders are holding 4.327% of the shares of PDS Biotechnology Corp.

DateOwnerTypeAmountPricePost Transaction AmountLink
2021-12-13Matthew C HillBUY29008.99
2021-06-15Steve C GloverBUY58828.5
2021-06-15Voorhees Seth VanBUY176478.5

4. Summary

4.1. Key Performance Indicators

The key performance indicators of PDS Biotechnology Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.038-0.147+487%-0.154+506%-0.007+118%0.022+71%
Book Value Per Share--0.8250.993-17%1.594-48%1.154-28%1.419-42%
Current Ratio--4.3338.754-51%11.901-64%10.199-58%10.221-58%
Debt To Asset Ratio--0.5600.506+11%0.242+132%0.231+142%0.396+41%
Debt To Equity Ratio--1.2731.061+20%0.381+234%0.386+230%0.315+304%
Dividend Per Share----0%0.000-100%0.000-100%0.000-100%
Eps---0.344-0.3440%-0.328-5%-0.197-43%-0.204-41%
Free Cash Flow Per Share---0.267-0.269+1%-0.207-23%-0.165-38%-0.205-23%
Free Cash Flow To Equity Per Share--0.073-0.139+291%0.069+6%49.248-100%9.056-99%
Gross Profit Margin--1.0011.000+0%1.000+0%1.000+0%1.000+0%
Intrinsic Value_10Y_max---13.260--------
Intrinsic Value_10Y_min---11.285--------
Intrinsic Value_1Y_max---0.850--------
Intrinsic Value_1Y_min---0.835--------
Intrinsic Value_3Y_max---2.920--------
Intrinsic Value_3Y_min---2.780--------
Intrinsic Value_5Y_max---5.428--------
Intrinsic Value_5Y_min---5.007--------
Market Cap101100350.000-56%157396639.680165569058.420-5%202278469.500-22%177354458.724-11%187081229.845-16%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio3.939-53%6.0235.482+10%4.237+42%5.135+17%3.560+69%
Pe Ratio-2.361+35%-3.611-3.893+8%-4.759+32%-13.356+270%-16.700+363%
Price Per Share3.250-53%4.9705.300-6%6.503-24%5.697-13%6.012-17%
Price To Free Cash Flow Ratio-3.043+35%-4.653-5.469+18%-7.477+61%-2.734-41%-4.302-8%
Price To Total Gains Ratio85.405-53%130.6047.161+1724%-51.818+140%-26.535+120%-21.854+117%
Quick Ratio--4.1508.384-51%11.445-64%9.735-57%9.906-58%
Return On Assets---0.184-0.174-5%-0.155-15%-0.135-27%-0.136-26%
Return On Equity---0.417-0.363-13%-0.228-45%-0.199-52%-0.171-59%
Total Gains Per Share--0.038-0.147+487%-0.154+506%-0.007+118%0.022+71%
Usd Book Value--26130947.00031017479.250-16%49589857.000-47%35912686.400-27%44140801.243-41%
Usd Book Value Change Per Share--0.038-0.147+487%-0.154+506%-0.007+118%0.022+71%
Usd Book Value Per Share--0.8250.993-17%1.594-48%1.154-28%1.419-42%
Usd Dividend Per Share----0%0.000-100%0.000-100%0.000-100%
Usd Eps---0.344-0.3440%-0.328-5%-0.197-43%-0.204-41%
Usd Free Cash Flow---8457176.000-8409034.000-1%-6427426.500-24%-5152725.600-39%-6392720.541-24%
Usd Free Cash Flow Per Share---0.267-0.269+1%-0.207-23%-0.165-38%-0.205-23%
Usd Free Cash Flow To Equity Per Share--0.073-0.139+291%0.069+6%49.248-100%9.056-99%
Usd Market Cap101100350.000-56%157396639.680165569058.420-5%202278469.500-22%177354458.724-11%187081229.845-16%
Usd Price Per Share3.250-53%4.9705.300-6%6.503-24%5.697-13%6.012-17%
Usd Profit---10898216.000-10734760.750-1%-10811741.250-1%-6247523.600-43%-7749754.676-29%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share--0.038-0.147+487%-0.154+506%-0.007+118%0.022+71%
 EOD+2 -6MRQTTM+11 -19YOY+9 -235Y+8 -2410Y+8 -24

4.2. Fundamental Score

Let's check the fundamental score of PDS Biotechnology Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.361
Price to Book Ratio (EOD)Between0-13.939
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than14.150
Current Ratio (MRQ)Greater than14.333
Debt to Asset Ratio (MRQ)Less than10.560
Debt to Equity Ratio (MRQ)Less than11.273
Return on Equity (MRQ)Greater than0.15-0.417
Return on Assets (MRQ)Greater than0.05-0.184
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of PDS Biotechnology Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.859
Ma 20Greater thanMa 503.268
Ma 50Greater thanMa 1004.502
Ma 100Greater thanMa 2004.796
OpenGreater thanClose3.250
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets59,390
Total Liabilities33,259
Total Stockholder Equity26,131
 As reported
Total Liabilities 33,259
Total Stockholder Equity+ 26,131
Total Assets = 59,390

Assets

Total Assets59,390
Total Current Assets59,055
Long-term Assets335
Total Current Assets
Cash And Cash Equivalents 56,561
Other Current Assets 2,495
Total Current Assets  (as reported)59,055
Total Current Assets  (calculated)59,055
+/-0
Long-term Assets
Property Plant Equipment 335
Long-term Assets Other 0
Long-term Assets  (as reported)335
Long-term Assets  (calculated)335
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities13,630
Long-term Liabilities19,629
Total Stockholder Equity26,131
Total Current Liabilities
Short-term Debt 4,222
Short Long Term Debt 4,167
Accounts payable 6,983
Other Current Liabilities 2,425
Total Current Liabilities  (as reported)13,630
Total Current Liabilities  (calculated)17,797
+/- 4,167
Long-term Liabilities
Long term Debt 19,506
Capital Lease Obligations 179
Long-term Liabilities  (as reported)19,629
Long-term Liabilities  (calculated)19,685
+/- 56
Total Stockholder Equity
Common Stock11
Retained Earnings -144,501
Other Stockholders Equity 170,621
Total Stockholder Equity (as reported)26,131
Total Stockholder Equity (calculated)26,131
+/-0
Other
Capital Stock11
Cash and Short Term Investments 56,561
Common Stock Shares Outstanding 31,669
Liabilities and Stockholders Equity 59,390
Net Debt -32,709
Net Invested Capital 49,804
Net Working Capital 45,425
Property Plant and Equipment Gross 468
Short Long Term Debt Total 23,852



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-30
> Total Assets 
0
17,047
0
62,685
58,483
134,093
123,766
115,420
116,579
110,914
99,898
112,986
101,239
92,621
76,609
47,212
37,673
36,221
31,046
25,804
19,383
14,491
23,934
20,093
34,445
30,890
27,762
77,391
71,748
67,198
61,039
56,001
74,887
77,008
68,449
63,754
57,188
59,390
59,39057,18863,75468,44977,00874,88756,00161,03967,19871,74877,39127,76230,89034,44520,09323,93414,49119,38325,80431,04636,22137,67347,21276,60992,621101,239112,98699,898110,914116,579115,420123,766134,09358,48362,685017,0470
   > Total Current Assets 
0
15,442
0
60,430
55,597
131,271
120,784
111,816
113,144
107,354
96,290
109,351
97,634
89,054
75,914
46,559
37,062
35,651
27,907
22,833
18,134
14,470
23,917
19,441
33,842
30,337
27,257
76,934
71,341
66,840
60,731
55,743
74,411
76,480
67,973
63,351
56,838
59,055
59,05556,83863,35167,97376,48074,41155,74360,73166,84071,34176,93427,25730,33733,84219,44123,91714,47018,13422,83327,90735,65137,06246,55975,91489,05497,634109,35196,290107,354113,144111,816120,784131,27155,59760,430015,4420
       Cash And Cash Equivalents 
0
13,729
0
58,465
52,880
130,189
119,942
111,022
112,785
106,399
95,591
108,715
97,307
88,068
74,997
45,979
36,815
34,646
26,593
21,734
17,407
12,162
21,038
16,934
33,469
28,840
25,037
74,749
69,744
65,243
58,881
52,985
71,642
73,820
65,199
60,625
54,251
56,561
56,56154,25160,62565,19973,82071,64252,98558,88165,24369,74474,74925,03728,84033,46916,93421,03812,16217,40721,73426,59334,64636,81545,97974,99788,06897,307108,71595,591106,399112,785111,022119,942130,18952,88058,465013,7290
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000040000000000000
       Other Current Assets 
0
1,405
0
1,626
2,378
1,081
842
794
360
955
700
637
327
987
917
580
247
1,006
1,314
1,099
727
2,308
2,879
2,507
373
1,498
2,220
2,185
1,597
1,598
1,849
2,758
2,769
2,660
2,774
2,726
2,587
2,495
2,4952,5872,7262,7742,6602,7692,7581,8491,5981,5972,1852,2201,4983732,5072,8792,3087271,0991,3141,0062475809179873276377009553607948421,0812,3781,62601,4050
   > Long-term Assets 
0
1,605
0
2,255
2,886
2,822
2,982
3,604
3,435
3,561
3,608
3,634
3,605
3,567
696
653
611
570
3,139
2,971
1,250
21
17
652
603
553
505
456
407
358
308
258
475
528
475
403
349
335
33534940347552847525830835840745650555360365217211,2502,9713,1395706116536963,5673,6053,6343,6083,5613,4353,6042,9822,8222,8862,25501,6050
       Property Plant Equipment 
0
1,444
0
2,134
2,782
2,767
2,839
3,461
3,292
3,418
3,465
3,492
3,462
3,424
553
510
468
427
1,760
1,603
27
21
17
652
603
553
505
456
407
358
308
258
475
528
475
403
349
335
3353494034755284752583083584074565055536036521721271,6031,7604274685105533,4243,4623,4923,4653,4183,2923,4612,8392,7672,7822,13401,4440
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
47
0
0
43
42
1,223
1,223
1,223
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000001,2231,2231,223424300470000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
11
0
0
11
13
156
145
0
0
0
0
0
548
0
0
0
0
0
0
0
0
0
0
0
0
00000000000054800000145156131100110000000000000
> Total Liabilities 
0
44,880
0
10,546
109,127
11,615
9,043
8,664
19,071
21,638
21,251
28,718
26,585
30,250
32,330
13,870
6,688
6,382
6,598
5,199
3,801
2,794
4,047
3,079
3,420
3,761
3,387
4,398
3,891
3,987
5,165
4,576
27,828
33,006
27,438
31,310
32,704
33,259
33,25932,70431,31027,43833,00627,8284,5765,1653,9873,8914,3983,3873,7613,4203,0794,0472,7943,8015,1996,5986,3826,68813,87032,33030,25026,58528,71821,25121,63819,0718,6649,04311,615109,12710,546044,8800
   > Total Current Liabilities 
0
3,893
0
4,030
8,450
8,590
6,571
6,764
4,254
6,685
6,746
11,590
11,702
12,867
32,330
13,870
6,688
6,382
5,538
4,267
3,644
2,794
4,047
2,526
2,899
3,270
2,929
4,003
3,577
3,756
5,018
4,516
4,841
9,821
4,130
7,904
9,154
13,630
13,6309,1547,9044,1309,8214,8414,5165,0183,7563,5774,0032,9293,2702,8992,5264,0472,7943,6444,2675,5386,3826,68813,87032,33012,86711,70211,5906,7466,6854,2546,7646,5718,5908,4504,03003,8930
       Short-term Debt 
0
265
0
1,641
2,215
2,271
2,329
2,389
0
0
580
3,086
5,455
3,075
20,900
0
0
0
477
492
0
0
0
113
116
120
124
158
208
259
311
335
375
288
199
113
55
4,222
4,2225511319928837533531125920815812412011611300049247700020,9003,0755,4553,086580002,3892,3292,2712,2151,64102650
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
477
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,167
4,167000000000000000000477000000000000000000
       Accounts payable 
0
2,046
0
1,084
2,645
2,584
2,883
2,855
1,963
3,471
2,528
4,350
2,965
4,369
2,957
1,723
591
399
2,665
1,853
1,489
1,198
2,557
1,093
1,560
1,415
951
2,375
1,446
1,309
2,746
1,878
2,037
1,219
2,072
4,415
5,367
6,983
6,9835,3674,4152,0721,2192,0371,8782,7461,3091,4462,3759511,4151,5601,0932,5571,1981,4891,8532,6653995911,7232,9574,3692,9654,3502,5283,4711,9632,8552,8832,5842,6451,08402,0460
       Other Current Liabilities 
0
1,847
0
2,945
5,805
3,734
1,358
1,520
2,290
3,214
3,639
4,154
3,282
5,422
8,473
12,146
6,098
5,982
1,949
1,284
2,155
1,596
1,490
127
1,339
-19,045
1,855
1,470
1,924
2,188
1,961
2,303
2,429
8,314
1,858
3,376,325
3,732,727
2,425
2,4253,732,7273,376,3251,8588,3142,4292,3031,9612,1881,9241,4701,855-19,0451,3391271,4901,5962,1551,2841,9495,9826,09812,1468,4735,4223,2824,1543,6393,2142,2901,5201,3583,7345,8052,94501,8470
   > Long-term Liabilities 
0
40,987
0
6,516
100,677
3,025
2,472
1,900
14,817
14,953
14,506
17,127
14,883
17,383
17,383
0
0
0
1,060
931
157
0
0
552
522
490
458
395
314
231
147
60
22,987
23,185
23,308
23,406
23,550
19,629
19,62923,55023,40623,30823,18522,98760147231314395458490522552001579311,06000017,38317,38314,88317,12714,50614,95314,8171,9002,4723,025100,6776,516040,9870
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
22,910
23,021
23,143
23,254
0
0
0023,25423,14323,02122,91000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
157
157
157
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000157157157000000000000000000
> Total Stockholder Equity
0
-27,834
0
52,139
-50,644
122,478
114,723
106,756
97,508
89,277
78,647
84,268
74,654
62,371
44,279
33,343
30,985
29,839
24,448
20,606
15,583
11,698
19,888
17,014
31,025
27,130
24,374
72,993
67,857
63,210
55,873
51,425
47,059
44,002
41,011
32,444
24,484
26,131
26,13124,48432,44441,01144,00247,05951,42555,87363,21067,85772,99324,37427,13031,02517,01419,88811,69815,58320,60624,44829,83930,98533,34344,27962,37174,65484,26878,64789,27797,508106,756114,723122,478-50,64452,1390-27,8340
   Common Stock
0
1
0
9
1
10
10
10
10
10
10
10
10
10
11
11
11
11
2
2
2
2
5
5
7
7
7
9
9
9
9
9
9
10
10
10
10
11
11101010109999997775522221111111110101010101010101019010
   Retained Earnings Total Equity00-122,753-111,218-101,558-82,421-74,996-69,1770-54,384-47,423-46,834-43,7850000000000000000000000000
   Accumulated Other Comprehensive Income 000000000000000-94-94000-45200-305-30500-122-12200-91-910-620-380
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
222,645
38,642
38,686
39,415
40,634
52,806
0
0
70,907
71,201
120,406
122,231
0
125,041
126,412
129,470
145,550
152,219
155,187
0
0
00155,187152,219145,550129,470126,412125,0410122,231120,40671,20170,9070052,80640,63439,41538,68638,642222,64500000000000000000
   Treasury Stock00000000000000000000000000000000000000
   Other Stockholders Equity 
0
2,023
0
94,430
-89,714
184,813
186,138
187,547
189,058
190,464
191,896
211,021
212,688
214,615
217,057
218,798
220,706
223,097
38,642
38,686
39,415
40,728
52,806
52,862
70,776
70,907
71,201
120,406
122,231
123,905
125,041
126,412
129,470
145,550
152,219
155,187
158,076
170,621
170,621158,076155,187152,219145,550129,470126,412125,041123,905122,231120,40671,20170,90770,77652,86252,80640,72839,41538,68638,642223,097220,706218,798217,057214,615212,688211,021191,896190,464189,058187,547186,138184,813-89,71494,43002,0230



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-57
Gross Profit-57-57
 
Operating Income (+$)
Gross Profit-57
Operating Expense-42,988
Operating Income-43,045-43,045
 
Operating Expense (+$)
Research Development27,763
Selling General Administrative15,007
Selling And Marketing Expenses0
Operating Expense42,98842,770
 
Net Interest Income (+$)
Interest Income2,822
Interest Expense-4,206
Other Finance Cost-256
Net Interest Income-1,128
 
Pretax Income (+$)
Operating Income-43,045
Net Interest Income-1,128
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-44,348-41,742
EBIT - interestExpense = -47,251
-44,348
-38,736
Interest Expense4,206
Earnings Before Interest and Taxes (EBIT)-43,045-40,142
Earnings Before Interest and Taxes (EBITDA)-42,988
 
After tax Income (+$)
Income Before Tax-44,348
Tax Provision--1,406
Net Income From Continuing Ops-51,182-42,942
Net Income-42,942
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses43,045
Total Other Income/Expenses Net-1,3031,128
 

Technical Analysis of PDS Biotechnology Corp
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of PDS Biotechnology Corp. The general trend of PDS Biotechnology Corp is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine PDS Biotechnology Corp's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of PDS Biotechnology Corp.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 3.8 < 4.48 < 4.94.

The bearish price targets are: .

Tweet this
PDS Biotechnology Corp Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of PDS Biotechnology Corp. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

PDS Biotechnology Corp Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of PDS Biotechnology Corp. The current macd is -0.43182258.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the PDS Biotechnology Corp price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for PDS Biotechnology Corp. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the PDS Biotechnology Corp price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
PDS Biotechnology Corp Daily Moving Average Convergence/Divergence (MACD) ChartPDS Biotechnology Corp Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of PDS Biotechnology Corp. The current adx is 37.89.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell PDS Biotechnology Corp shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
PDS Biotechnology Corp Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of PDS Biotechnology Corp. The current sar is 2.6032.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
PDS Biotechnology Corp Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of PDS Biotechnology Corp. The current rsi is 42.86. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
PDS Biotechnology Corp Daily Relative Strength Index (RSI) ChartPDS Biotechnology Corp Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of PDS Biotechnology Corp. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the PDS Biotechnology Corp price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
PDS Biotechnology Corp Daily Stochastic Oscillator ChartPDS Biotechnology Corp Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of PDS Biotechnology Corp. The current cci is -8.28954259.

PDS Biotechnology Corp Daily Commodity Channel Index (CCI) ChartPDS Biotechnology Corp Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of PDS Biotechnology Corp. The current cmo is -2.17895737.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
PDS Biotechnology Corp Daily Chande Momentum Oscillator (CMO) ChartPDS Biotechnology Corp Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of PDS Biotechnology Corp. The current willr is -19.51219512.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
PDS Biotechnology Corp Daily Williams %R ChartPDS Biotechnology Corp Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of PDS Biotechnology Corp.

PDS Biotechnology Corp Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of PDS Biotechnology Corp. The current atr is 0.31110073.

PDS Biotechnology Corp Daily Average True Range (ATR) ChartPDS Biotechnology Corp Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of PDS Biotechnology Corp. The current obv is 9,686,605.

PDS Biotechnology Corp Daily On-Balance Volume (OBV) ChartPDS Biotechnology Corp Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of PDS Biotechnology Corp. The current mfi is 41.37.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
PDS Biotechnology Corp Daily Money Flow Index (MFI) ChartPDS Biotechnology Corp Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for PDS Biotechnology Corp.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-25WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-29BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-04BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-24WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

PDS Biotechnology Corp Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of PDS Biotechnology Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.859
Ma 20Greater thanMa 503.268
Ma 50Greater thanMa 1004.502
Ma 100Greater thanMa 2004.796
OpenGreater thanClose3.250
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of PDS Biotechnology Corp with someone you think should read this too:
  • Are you bullish or bearish on PDS Biotechnology Corp? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about PDS Biotechnology Corp? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about PDS Biotechnology Corp

I send you an email if I find something interesting about PDS Biotechnology Corp.


Comments

How you think about this?

Leave a comment

Stay informed about PDS Biotechnology Corp.

Receive notifications about PDS Biotechnology Corp in your mailbox!